JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120254

5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist

Be the first to review this product! Submit a review

|

(1 Publication)

MW 280.04 Da, Purity >99%. Potent NMDA receptor glycine site antagonist. Achieve your results faster with highly validated, pure and trusted compounds.
2 Images
Functional Studies - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (AB120254)
  • FuncS

Unknown

Functional Studies - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (AB120254)

ab12416 staining cGMP in SKNSH cells treated with 5,7-Dichlorokynurenic acid sodium salt (ab120254), by ICC/IF. Decrease in cGMP expression correlates with increased concentration of 5,7-Dichlorokynurenic acid sodium salt, as described in literature.
The cells were incubated at 37°C for 20 minutes in media containing different concentrations of ab120254 (5,7-Dichlorokynurenic acid sodium salt) in DMSO. Some samples where then further incubated with 15 µM NMDA (ab120052) for 5 minutes and all samples were fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab12416 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight® 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with D

Chemical Structure - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (AB120254)
  • Chemical Structure

Lab

Chemical Structure - 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist (AB120254)

2D chemical structure image of ab120254, 5,7-Dichlorokynurenic acid sodium salt, NMDA receptor glycine site antagonist

Key facts

CAS number

1184986-70-6

Purity

>99%

Form

Solid

form

Molecular weight

280.04 Da

Molecular formula

C<sub>1</sub><sub>0</sub>H<sub>4</sub>Cl<sub>2</sub>NNaO<sub>3</sub>

PubChem

44134672

Nature

Synthetic

Biochemical name

5,7-Dichlorokynurenic acid sodium salt

Biological description

Potent NMDA receptor glycine site antagonist.

Canonical smiles

C1=C(C=C(C2=C1NC(=CC2=O)C(=O)[O-])Cl)Cl.[Na+]

InChi

InChI=1S/C10H5Cl2NO3.Na/c11-4-1-5(12)9-6(2-4)13-7(10(15)16)3-8(9)14;/h1-3H,(H,13,14)(H,15,16);/q;+1/p-1

InChiKey

VPRPMJHKWHCUFW-UHFFFAOYSA-M

IUPAC Name

sodium;5,7-dichloro-4-oxo-1H-quinoline-2-carboxylate

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Glutamate Receptor 1 (AMPA subtype) also known as GluR1 is a subunit of the AMPA receptor complex which mediates fast synaptic transmission in the central nervous system. It is an ionotropic receptor for glutamate functioning by opening ion channels to allow the flow of Na+ and Ca2+ ions across the cell membrane contributing to excitatory neurotransmission. The GluR1 subunit has a molecular mass of approximately 100 kDa. This receptor is commonly expressed in the brain regions such as the hippocampus and the cerebral cortex playing an important role in synaptic plasticity and memory formation.
Biological function summary

The GluR1 subunit is an essential component of the AMPA receptor complex which typically forms as a tetramer. This complex modulates synaptic strength and plasticity processes critical for learning and memory. The activity of AMPA receptors including those containing GluR1 is regulated by several auxiliary proteins and is essential for post-synaptic responses. The GluR1 subunit also interacts with other proteins such as TARPs which modulate its trafficking and channel properties.

Pathways

The GluR1-containing AMPA receptors participate significantly in the glutamatergic signaling pathway which is vital for fast excitatory synaptic transmission in the brain. This pathway also involves the NMDA receptors which work together with AMPA receptors to regulate synaptic plasticity and neuronal communication. Additionally the GluR1 interacts within the long-term potentiation (LTP) pathway contributing to the strengthening of synapses an essential mechanism underlying learning and memory.

Dysfunction in GluR1 and associated AMPA receptors has been implicated in conditions like Alzheimer's disease and epilepsy. Alzheimer's disease exhibits decreased synaptic transmission and plasticity linked to impaired GluR1 function and its interactions with NMDA receptors. In epilepsy abnormal GluR1 activity may contribute to heightened neuronal excitability and seizure propagation. Targeting GluR1 or associated pathways offers potential for therapeutic interventions in these disorders possibly through drugs such as memantine and NBQX which modulate receptor activity.

Product protocols

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Nature communications 15:8841 PubMed39396999

2024

Bi-directional allosteric pathway in NMDA receptor activation and modulation.

Applications

Unspecified application

Species

Unspecified reactive species

Paula A Bender,Subhajit Chakraborty,Ryan J Durham,Vladimir Berka,Elisa Carrillo,Vasanthi Jayaraman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com